J&J Unit Agrees To Risperdal Deal Ahead Of Philly Trial

Law360 (October 19, 2018, 4:18 PM EDT) -- In advance of a trial that was slated to get underway Monday in Pennsylvania state court, a Johnson & Johnson unit has agreed to settle claims from a Mississippi family who says their son developed breasts after taking the antipsychotic drug Risperdal to treat a conduct disorder.

Monday's settlement comes as J&J subsidiary Janssen Pharmaceuticals Inc. begins to face the prospect of punitive damage awards in Risperdal cases in Philadelphia County following a Superior Court ruling in January that upended a global order barring punitive damages for any claims related to the drug.

The case that was set for trial involved...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS